Associations Between Maternal Lipid Profile and Pregnancy Complications and Perinatal Outcomes: a Population-based Study from China

Overview

Journal BMC Pregnancy Childbirth

Publisher Biomed Central

Specialty Gynecology & Obstetrics

Date 2016 Mar 23

PMID 27000102

Citations 119

Authors

Wen-Yuan Jin

Sheng-Liang Lin

Ruo-Lin Hou

Xiao-Yang Chen

Ting Han

Yan Jin

Li Tang

Zhi-Wei Zhu

Zheng-Yan Zhao

Affiliations

Soon will be listed here.

Abstract

Background: Dyslipidemia in pregnancy are associated with gestational diabetes mellitus (GDM), preeclampsia, preterm birth and other adverse outcomes, which has been extensively studied in western countries. However, similar studies have rarely been conducted in Asian countries. Our study was aimed at investigating the associations between maternal dyslipidemia and adverse pregnancy outcomes among Chinese population.

Methods: Data were derived from 934 pairs of non-diabetic mothers and neonates between 2010 and 2011. Serum blood samples were assayed for fasting total cholesterol (TC), triglycerides (TG), high-density lipoprotein-cholesterol (HDL-C), and low-density lipoprotein-cholesterol (LDL-C) concentrations during the first, second and third trimesters. The present study explored the associations between maternal lipid profile and pregnancy complications and perinatal outcomes. The pregnancy complications included GDM, preeclampsia and intrahepatic cholestasis of pregnancy (ICP); the perinatal outcomes included preterm birth, small/large for gestational age (SGA/LGA) infants and macrosomia. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated and adjusted via stepwise logistic regression analysis. Optimal cut-off points were determined by ROC curve analysis.

Results: After adjustments for confounders, every unit elevation in third-trimester TG concentration was associated with increased risk for GDM (OR = 1.37, 95% CI: 1.18-1.58), preeclampsia (OR = 1.50, 95% CI: 1.16-1.93), ICP (OR = 1.28, 95% CI: 1.09-1.51), LGA (OR = 1.13, 95% CI: 1.02-1.26), macrosomia (OR = 1.19, 95% CI: 1.02-1.39) and decreased risk for SGA (OR = 0.63, 95% CI: 0.40-0.99); every unit increase in HDL-C concentration was associated with decreased risk for GDM and macrosomia, especially during the second trimester (GDM: OR = 0.10, 95% CI: 0.03-0.31; macrosomia: OR = 0.25, 95% CI: 0.09-0.73). The optimal cut-off points for third-trimester TG predicting GDM, preeclampsia, ICP, LGA and SGA were separately ≥ 3.871, 3.528, 3.177, 3.534 and ≤ 2.530 mmol/L. The optimal cut-off points for third-trimester HDL-C identifying GDM, macrosomia and SGA were respectively ≤ 1.712, 1.817 and ≥ 2.238 mmol/L.

Conclusions: Among Chinese population, maternal high TG in late pregnancy was independently associated with increased risk of GDM, preeclampsia, ICP, LGA, macrosomia and decreased risk of SGA. Relative low maternal HDL-C during pregnancy was significantly associated with increased risk of GDM and macrosomia; whereas relative high HDL-C was a protective factor for both of them.

Citing Articles

Association of Overnight Fasting Duration and Meal Frequency with Glucose and Lipid Metabolism During Pregnancy: A Cross-Sectional Study.

Nakano K, Tanaka M, Nishihara N, Usui Y, Yonezawa K, Hikita N Nutrients. 2025; 17(5).

PMID: 40077677 PMC: 11901530. DOI: 10.3390/nu17050807.

Global and regional incidence of intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis.

Jamshidi Kerachi A, Shahlaee M, Habibi P, Dehdari Ebrahimi N, Ala M, Sadeghi A BMC Med. 2025; 23(1):129.

PMID: 40022113 PMC: 11871686. DOI: 10.1186/s12916-025-03935-0.

Correlation between lipid metabolism levels and pregnancy outcomes.

Guo J, Qiu H, Wang J, Liu X, Chen S, Li B Front Med (Lausanne). 2025; 12:1530525.

PMID: 40012983 PMC: 11862992. DOI: 10.3389/fmed.2025.1530525.

Trimester-specific reference intervals for blood lipid levels and their associations with adverse pregnancy outcomes in Southeast China.

Yang L, Liu Z, Chen J, Miao C, Li Q, Chen J Lipids Health Dis. 2025; 24(1):68.

PMID: 39987069 PMC: 11846285. DOI: 10.1186/s12944-025-02494-w.

Establishment and validation of a nomogram for predicting preterm birth in intrahepatic cholestasis during pregnancy: a retrospective study.

Xie W, Ji L, Luo D, Ye L, Li Q, Kang L BMC Pregnancy Childbirth. 2025; 25(1):194.

PMID: 39984873 PMC: 11846180. DOI: 10.1186/s12884-025-07320-w.

References

Di Cianni G, Miccoli R, Volpe L, Lencioni C, Ghio A, Giovannitti M . Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance. Diabet Med. 2004; 22(1):21-5. DOI: 10.1111/j.1464-5491.2004.01336.x. View

Savona-Ventura C, Vassallo J, Craus J, Anastasiou E, Jotic A, Lalic N . Biological and biochemical characteristics of a Mediterranean population with Gestational Diabetes Mellitus. J Perinat Med. 2015; 44(4):377-82. DOI: 10.1515/jpm-2015-0027. View

Gillman M . Developmental origins of health and disease. N Engl J Med. 2005; 353(17):1848-50. PMC: 1488726. DOI: 10.1056/NEJMe058187. View

Sanchez S, Williams M, Muy-Rivera M, Qiu C, Vadachkoria S, Bazul V . A case-control study of oxidized low density lipoproteins and preeclampsia risk. Gynecol Endocrinol. 2005; 21(4):193-9. DOI: 10.1080/09513590500154019. View

Kaaja R, Greer I . Manifestations of chronic disease during pregnancy. JAMA. 2005; 294(21):2751-7. DOI: 10.1001/jama.294.21.2751. View

Qiu C, Phung T, Vadachkoria S, Muy-Rivera M, Sanchez S, Williams M . Oxidized low-density lipoprotein (Oxidized LDL) and the risk of preeclampsia. Physiol Res. 2005; 55(5):491-500. DOI: 10.33549/physiolres.930813. View

Lippi G, Albiero A, Montagnana M, Salvagno G, Scevarolli S, Franchi M . Lipid and lipoprotein profile in physiological pregnancy. Clin Lab. 2007; 53(3-4):173-7. View

Sanchez-Vera I, Bonet B, Viana M, Quintanar A, Martin M, Blanco P . Changes in plasma lipids and increased low-density lipoprotein susceptibility to oxidation in pregnancies complicated by gestational diabetes: consequences of obesity. Metabolism. 2007; 56(11):1527-33. DOI: 10.1016/j.metabol.2007.06.020. View

Qiu C, Rudra C, Austin M, Williams M . Association of gestational diabetes mellitus and low-density lipoprotein (LDL) particle size. Physiol Res. 2007; 56(5):571-578. DOI: 10.33549/physiolres.931073. View

10.

Catov J, Bodnar L, Kip K, Hubel C, Ness R, Harger G . Early pregnancy lipid concentrations and spontaneous preterm birth. Am J Obstet Gynecol. 2007; 197(6):610.e1-7. DOI: 10.1016/j.ajog.2007.04.024. View

11.

Husain F, Latif S, Uddin M, Nessa A . Lipid profile changes in second trimester of pregnancy. Mymensingh Med J. 2008; 17(1):17-21. View

12.

Schaefer-Graf U, Graf K, Kulbacka I, Kjos S, Dudenhausen J, Vetter K . Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care. 2008; 31(9):1858-63. PMC: 2518359. DOI: 10.2337/dc08-0039. View

13.

Rizzo M, Berneis K, Altinova A, Toruner F, Akturk M, Ayvaz G . Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. Diabet Med. 2008; 25(12):1406-11. DOI: 10.1111/j.1464-5491.2008.02613.x. View

14.

Baker A, Klein R, Moss K, Haeri S, Boggess K . Maternal serum dyslipidemia occurs early in pregnancy in women with mild but not severe preeclampsia. Am J Obstet Gynecol. 2009; 201(3):293.e1-4. DOI: 10.1016/j.ajog.2009.05.037. View

15.

Wiznitzer A, Mayer A, Novack V, Sheiner E, Gilutz H, Malhotra A . Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study. Am J Obstet Gynecol. 2009; 201(5):482.e1-8. PMC: 5483324. DOI: 10.1016/j.ajog.2009.05.032. View

16.

Fiorucci S, Mencarelli A, Palladino G, Cipriani S . Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders. Trends Pharmacol Sci. 2009; 30(11):570-80. DOI: 10.1016/j.tips.2009.08.001. View

17.

Metzger B, Gabbe S, Persson B, Buchanan T, Catalano P, Damm P . International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010; 33(3):676-82. PMC: 2827530. DOI: 10.2337/dc09-1848. View

18.

Gobl C, Handisurya A, Klein K, Bozkurt L, Luger A, Bancher-Todesca D . Changes in serum lipid levels during pregnancy in type 1 and type 2 diabetic subjects. Diabetes Care. 2010; 33(9):2071-3. PMC: 2928366. DOI: 10.2337/dc10-0484. View

19.

Retnakaran R, Qi Y, Connelly P, Sermer M, Hanley A, Zinman B . The graded relationship between glucose tolerance status in pregnancy and postpartum levels of low-density-lipoprotein cholesterol and apolipoprotein B in young women: implications for future cardiovascular risk. J Clin Endocrinol Metab. 2010; 95(9):4345-53. DOI: 10.1210/jc.2010-0361. View

20.

Herrera E, Ortega-Senovilla H . Disturbances in lipid metabolism in diabetic pregnancy - Are these the cause of the problem?. Best Pract Res Clin Endocrinol Metab. 2010; 24(4):515-25. DOI: 10.1016/j.beem.2010.05.006. View